Elgethun Capital Management Has $3.34 Million Stake in UnitedHealth Group Incorporated $UNH

Elgethun Capital Management lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 42.9% during the second quarter, HoldingsChannel reports. The firm owned 10,692 shares of the healthcare conglomerate’s stock after acquiring an additional 3,209 shares during the quarter. Elgethun Capital Management’s holdings in UnitedHealth Group were worth $3,336,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of UNH. Caitlin John LLC increased its stake in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Murphy Pohlad Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 21.8% during the second quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after buying an additional 791 shares in the last quarter. Triumph Capital Management acquired a new position in shares of UnitedHealth Group in the second quarter valued at about $1,324,000. Wealth Effects LLC boosted its holdings in UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares during the period. Finally, Towercrest Capital Management bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $236,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.1%

NYSE:UNH opened at $329.78 on Thursday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $622.83. The firm’s 50 day simple moving average is $343.60 and its 200 day simple moving average is $315.11. The company has a market cap of $298.73 billion, a PE ratio of 17.21, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.15 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s payout ratio is 46.14%.

Analysts Set New Price Targets

Several equities analysts have weighed in on UNH shares. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Bank of America raised their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Finally, Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.